Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Israel

Showing results (91-100 of 178) with videos related to

Pageof 18
Sort By:
Pain Medicine (Malden, Mass.)|August 17, 2017
Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label TrialLynn R Webster, Edward Michna, Arif Khan, et al.
Journal of Pain Research|October 26, 2023
Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced IllnessNeel Mehta, Neal E Slatkin, Robert J Israel, et al.
Pain Management|January 18, 2020
Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancerBruce H Chamberlain, Michelle Rhiner, Neal E Slatkin, et al.
Pain Practice : the Official Journal of World Institute of Pain|November 19, 2016
Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer PainRichard Rauck, Neal E Slatkin, Nancy Stambler, et al.
Magnetic Resonance Imaging|November 1, 1989
Correlation between liver iron content and magnetic resonance imaging in ratsJ Israel, E Unger, K Buetow, et al.
Journal of Pain Research|August 3, 2023
Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial DoseBruce H Chamberlain, Michelle Rhiner, Neal E Slatkin, et al.
Immunology|December 1, 1996
Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRnE J Israel, D F Wilsker, K C Hayes, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Cortisone strengthens the intestinal mucosal barrier in a rodent necrotizing enterocolitis modelE J Israel, E J Schiffrin, E A Carter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 25, 2021
The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studiesDarren M Brenner, Neal E Slatkin, Nancy Stambler, et al.
Gastroenterology|November 1, 1990
Prevention of necrotizing enterocolitis in the rat with prenatal cortisoneE J Israel, E J Schiffrin, E A Carter, et al.
Pageof 18

Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
Pain Medicine (Malden, Mass.)|August 17, 2017
Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label TrialLynn R Webster, Edward Michna, Arif Khan, et al.
Journal of Pain Research|October 26, 2023
Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced IllnessNeel Mehta, Neal E Slatkin, Robert J Israel, et al.
Pain Management|January 18, 2020
Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancerBruce H Chamberlain, Michelle Rhiner, Neal E Slatkin, et al.
Pain Practice : the Official Journal of World Institute of Pain|November 19, 2016
Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer PainRichard Rauck, Neal E Slatkin, Nancy Stambler, et al.
Magnetic Resonance Imaging|November 1, 1989
Correlation between liver iron content and magnetic resonance imaging in ratsJ Israel, E Unger, K Buetow, et al.
Journal of Pain Research|August 3, 2023
Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial DoseBruce H Chamberlain, Michelle Rhiner, Neal E Slatkin, et al.
Immunology|December 1, 1996
Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRnE J Israel, D F Wilsker, K C Hayes, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Cortisone strengthens the intestinal mucosal barrier in a rodent necrotizing enterocolitis modelE J Israel, E J Schiffrin, E A Carter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 25, 2021
The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studiesDarren M Brenner, Neal E Slatkin, Nancy Stambler, et al.
Gastroenterology|November 1, 1990
Prevention of necrotizing enterocolitis in the rat with prenatal cortisoneE J Israel, E J Schiffrin, E A Carter, et al.
Pageof 18